IQVIA HOLDINGS INC. (IQV)
Services-Commercial Physical & Biological Research · Services-Commercial Physical & Biological Research · NYSE
$249.28
+3.85%
Investingg Score
45.4 / 100
Sell
Business overview
- Operating margin stands at 13.4% based on the provided dataset.
- Free cash flow margin is recorded at 12.6%.
- Gross margin data is unavailable.
These figures demonstrate reasonable profitability in commercial physical and biological research, though the lack of gross margin data leaves some operational details uncertain.
Financial health
- Balance sheet pillar score is 9 out of 100 according to the model metrics.
- Free cash flow yield is 4.9%.
- Operating margin is reported at 13.4%.
Together, these metrics indicate low balance sheet quality despite positive operational cash generation.
- Gross Margin
- Data unavailable
- Operating Margin
- 13.4%
- Current Ratio
- 0.7x
- Debt / Equity
- 2.14
- Free Cash Flow (TTM)
- $2.1B
- Interest Coverage
- 3x
Valuation
- Price-to-earnings ratio is 37.75 based on recent data.
- Forward P/E ratio is 19.2.
- EV-to-EBITDA stands at 17.02 with a price-to-sales ratio of 2.63.
These diverse valuation multiples show a high trailing earnings multiple contrasted with a more moderate forward-looking expectation.
- P/E (TTM)
- 37.8x
- Forward P/E
- 19.2x
- Price / Sales
- 2.6x
- EV / EBITDA
- 17.0x
- FCF Yield
- 4.9%
Key risks
- Balance sheet pillar score is very low at 9.
- Overall Investingg Score indicates a Sell verdict at 45.4.
- Trailing P/E ratio is elevated at 37.75.
Market cap $42.3B · data as of 2026-08-19
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze IQV with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.